2022年1月11日,

微创手术减少恢复时间,展示了新的机遇在门诊医疗下载斯蒂芬·j·霍恩博士血管保健集团Leominster(照片:业务线)1月11日,2022年东部标准时间上午10:45 Leominster,质量。——(业务线)——血管治疗组(TVCG),一个先进的实践致力于预防、诊断和治疗的血管疾病,今天宣布Stephen j .洪尼格医学博士成功完成经皮femoral-popliteal Leominster动脉搭桥,质量。TVCG的位置,标记的第一个此类程序的门诊。TVCG周围集中处理模式优化病人的经验,提供先进的血管介入传统的医院外设置,和减轻不必要的费用。这种尖端的成功,微创手术标志着另一个任务的一步。过程是一个临床实验装置的一部分豁免(IDE)试验称为DETOUR2继续访问(NCT04625660),由Endologix LLC。试验的安全性和有效性评价的PQ旁路系统经皮femoral-popliteal搭桥手术。PQ旁路系统指定为美国食品和药物管理局(FDA)在2020年突破设备。“通过提供这种类型的微创手术在门诊,我们可以帮助患者避免手术切口,住院治疗和术后恢复,”霍恩博士说。“病人出院过程两个小时后没有不适,只有两个小,英寸的切口的访问。这显然改变了我们肢体威胁疾病的方法。 I feel privileged to be one of the first vascular surgeons in Massachusetts to perform the procedure.” Dr. Hoenig performed the procedure in his Leominster vascular center. The patient was placed under light conscious sedation and was sent home to recover a few hours later. This advancement in treatment was performed in concert with Vascular Breakthroughs, a clinical trials management platform. "This is an impressive achievement for both Dr. Hoenig and The Vascular Care Group,” said Dr. Paul Gagne, founder of Vascular Breakthroughs, the clinical trials research organization supporting Dr. Hoenig. “The procedure expands the possibilities of vascular care in the outpatient setting and provides patients with better outcomes in a patient-friendly environment.” The percutaneous bypass graft is used to restore blood flow to the lower leg and foot using a minimally invasive technique that avoids hospitalization and long recovery. With this new procedure, The Vascular Care Group is providing new technologies and techniques to community physicians working outside of large research centers, enabling greater access to medical innovation in a safe, efficient, patient-friendly setting. It marks another step in granting communities access to cutting-edge technology on a local level at a lower cost, without requiring a trip to a major city, or a long hospital stay. The PQ Bypass System is limited by federal law to investigational use only and is not available for sale. About The Vascular Care Group The Vascular Care Group (TVCG) is a growing group practice committed to the prevention, diagnosis, and treatment of vascular disease. The practice brings together decades of expertise among a team of vascular specialists offering unparalleled care in Massachusetts at four full-service vascular care centers with five satellite offices, from Worcester to Cape Cod. Their comprehensive services cover a broad range of conditions from non-invasive vascular testing to complex vascular surgeries, including a full spectrum of open and endovascular procedures performed in-office and at affiliated hospitals throughout the state. The care center has united some of the area’s leading vascular experts with a focus on superior patient care. More information about the practice can be found at https://vascularcaregrp.com/ . About Vascular Breakthroughs Vascular Breakthroughs was founded by Paul J. Gagne MD, FACS, RVT in 2012 to provide a research infrastructure for physicians not affiliated with an academic institution. The organization has put new technologies in the hands of physicians working in the community, thereby improving access to novel treatments for patients and expanding the reach of cutting-edge research. Vascular Breakthroughs provides administrative support for all aspects of the implementation of a clinical trial, including recruitment, all phases in the initiation of a new trial and in the execution of a trial. More information about Vascular Breakthroughs can be found at https://vascularbreakthroughs.com/ . Contacts